Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 41

1.

A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus.

Ameres S, Liang X, Wiesner M, Mautner J, Moosmann A.

Front Immunol. 2015 Nov 25;6:598. doi: 10.3389/fimmu.2015.00598. eCollection 2015.

2.

Drug Release and Targeting: the Versatility of Polymethacrylate Nanoparticles for Peroral Administration Revealed by Using an Optimized In Vitro-Toolbox.

Beyer S, Moosmann A, Kahnt AS, Ulshöfer T, Parnham MJ, Ferreirós N, Wagner S, Wacker MG.

Pharm Res. 2015 Dec;32(12):3986-98. doi: 10.1007/s11095-015-1759-2. Epub 2015 Jul 28.

PMID:
26216175
3.

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.

Rancan C, Schirrmann L, Hüls C, Zeidler R, Moosmann A.

PLoS Pathog. 2015 Jun 11;11(6):e1004906. doi: 10.1371/journal.ppat.1004906. eCollection 2015 Jun.

4.

Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings.

Tischer J, Engel N, Fritsch S, Prevalsek D, Hubmann M, Schulz C, Zoellner AK, Bücklein V, Reibke R, Mumm F, Rieger CT, Hill W, Ledderose G, Stemmler HJ, Köhnke T, Jäger G, Kolb HJ, Schmid C, Moosmann A, Hausmann A.

Ann Hematol. 2015 Oct;94(10):1677-88. doi: 10.1007/s00277-015-2423-y. Epub 2015 Jun 10.

PMID:
26055139
5.

Process development of periplasmatically produced single chain fragment variable against epidermal growth factor receptor in Escherichia coli.

Lindner R, Moosmann A, Dietrich A, Böttinger H, Kontermann R, Siemann-Herzberg M.

J Biotechnol. 2014 Dec 20;192 Pt A:136-45.

PMID:
25450642
6.

Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?

Kolb HJ, Schmetzer H, Schmid C, Bigalke I, Buhmann R, Moosmann A, Falk C, Reuther S, Schuster F, Borkhardt A.

Leuk Suppl. 2014 Dec;3(Suppl 1):S16-7. doi: 10.1038/leusup.2014.9. Epub 2014 Dec 17. No abstract available.

7.

Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cells.

Gabaev I, Elbasani E, Ameres S, Steinbrück L, Stanton R, Döring M, Lenac Rovis T, Kalinke U, Jonjic S, Moosmann A, Messerle M.

J Virol. 2014 Dec;88(24):14326-39. doi: 10.1128/JVI.01691-14. Epub 2014 Oct 1.

8.

CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity.

Ameres S, Besold K, Plachter B, Moosmann A.

J Immunol. 2014 Jun 15;192(12):5894-905. doi: 10.4049/jimmunol.1302281. Epub 2014 May 7.

9.

Purification of PEGylated proteins, with the example of PEGylated lysozyme and PEGylated scFv.

Moosmann A, Müller E, Böttinger H.

Methods Mol Biol. 2014;1129:527-38. doi: 10.1007/978-1-62703-977-2_37.

PMID:
24648098
10.

A palladium label to monitor nanoparticle-assisted drug delivery of a photosensitizer into tumor spheroids by elemental bioimaging.

Niehoff AC, Moosmann A, Söbbing J, Wiehe A, Mulac D, Wehe CA, Reifschneider O, Blaske F, Wagner S, Sperling M, von Briesen H, Langer K, Karst U.

Metallomics. 2014 Jan;6(1):77-81. doi: 10.1039/c3mt00223c.

PMID:
24311052
11.

Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.

Ameres S, Mautner J, Schlott F, Neuenhahn M, Busch DH, Plachter B, Moosmann A.

PLoS Pathog. 2013;9(5):e1003383. doi: 10.1371/journal.ppat.1003383. Epub 2013 May 23.

12.

Suppression of CD8+ T-cell recognition in the immediate-early phase of human cytomegalovirus infection.

Hesse J, Ameres S, Besold K, Krauter S, Moosmann A, Plachter B.

J Gen Virol. 2013 Feb;94(Pt 2):376-86. doi: 10.1099/vir.0.045682-0. Epub 2012 Oct 24.

PMID:
23100361
13.

Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic pool.

Fiebiger BM, Moosmann A, Behrends U, Mautner J.

Eur J Immunol. 2012 Dec;42(12):3167-73. doi: 10.1002/eji.201242627. Epub 2012 Oct 16.

14.

Specific CD8⁺ T cells recognize human herpesvirus 6B.

Martin LK, Schub A, Dillinger S, Moosmann A.

Eur J Immunol. 2012 Nov;42(11):2901-12. doi: 10.1002/eji.201242439. Epub 2012 Sep 26.

15.

The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.

Jochum S, Moosmann A, Lang S, Hammerschmidt W, Zeidler R.

PLoS Pathog. 2012;8(5):e1002704. doi: 10.1371/journal.ppat.1002704. Epub 2012 May 17.

16.

RNAs in Epstein-Barr virions control early steps of infection.

Jochum S, Ruiss R, Moosmann A, Hammerschmidt W, Zeidler R.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):E1396-404. doi: 10.1073/pnas.1115906109. Epub 2012 Apr 27.

17.

Purification of a PEGylated single chain Fv.

Moosmann A, Gerlach E, Lindner R, Böttinger H.

J Chromatogr A. 2012 May 4;1236:90-6. doi: 10.1016/j.chroma.2012.03.004. Epub 2012 Mar 8.

PMID:
22444429
18.

Aldehyde PEGylation kinetics: a standard protein versus a pharmaceutically relevant single chain variable fragment.

Moosmann A, Blath J, Lindner R, Müller E, Böttinger H.

Bioconjug Chem. 2011 Aug 17;22(8):1545-58. doi: 10.1021/bc200090x. Epub 2011 Aug 1.

PMID:
21780828
19.

Histone variant innovation in a rapidly evolving chordate lineage.

Moosmann A, Campsteijn C, Jansen PW, Nasrallah C, Raasholm M, Stunnenberg HG, Thompson EM.

BMC Evol Biol. 2011 Jul 15;11:208. doi: 10.1186/1471-2148-11-208.

20.

Virus-specific T cells for therapy--approaches, problems, solutions.

Moosmann A, Hammerschmidt W, Kolb HJ.

Eur J Cell Biol. 2012 Jan;91(1):97-101. doi: 10.1016/j.ejcb.2011.04.001. Epub 2011 Jun 2. Review.

PMID:
21640430
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk